Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

Company archive

Fisher & Paykel Healthcare (FPH) briefings

Read that company's published results in release order, newest first.

All briefingsConsumerHealthcareTransport & InfrastructurePrimary IndustriesPropertyInvestment CompaniesTechnologyConstruction & Materials
Open archive
Clear filters

Showing 1-7 of 7 published briefings.

Fisher & Paykel Healthcare (FPH)•FY26•Released 26 May 2026

FPH capex nearly doubled to NZ$195.2m, compressing FCF conversion

Operating cash flow rose to NZ$663.2m and cash built to NZ$461.1m, but capex hit 8.5% of revenue and FCF/NPAT fell to 95.3%.

Published 26 May 2026

Read briefing→
Fisher & Paykel Healthcare (FPH)•HY26•Released 26 November 2025

FPH PBT margin reached 26.1%, lifting profit 37.5% on 14.4% revenue growth

Operating leverage pushed margins above the recent historical range even as FCF conversion eased from 110.6% to 81.3% of NPAT.

Published 21 April 2026

Read briefing→
Fisher & Paykel Healthcare (FPH)•FY25•Released 28 May 2025

Operating cash flow more than doubled to $548.6m as capex normalised

Revenue crossed $2.0bn for the first time and FCF reached 113.3% of NPAT, signalling earnings backed by cash after years of heavy capex.

Published 22 April 2026

Read briefing→
Fisher & Paykel Healthcare (FPH)•HY25•Released 28 November 2024

FPH PBT up 46.8% as capex normalisation swings FCF positive

Operating leverage delivered above-baseline earnings growth while capex falling 80% to NZ$55.1m rebuilt FPH into a net cash position.

Published 22 April 2026

Read briefing→
Fisher & Paykel Healthcare (FPH)•HY24•Released 29 November 2023

Capex doubled to 34.3% of revenue, pre-lease FCF swung to NZ$127.5m negative

Revenue grew 16.4% and PBT 23.0%, but a doubled capex bill drove pre-lease FCF NZ$258.5m below the historical mean and left the dividend uncovered.

Published 22 April 2026

Read briefing→
Fisher & Paykel Healthcare (FPH)•FY23•Released 26 May 2023

FY23 FCF collapsed to $12.5m as capex stepped up 53%

H2 revenue rebounded 14%, but a 40.5c full-year dividend ran well past FCF cover with capex intensity climbing to 13.4% of revenue.

Published 22 April 2026

Read briefing→
Fisher & Paykel Healthcare (FPH)•HY23•Released 29 November 2022

Working capital absorbed NZ$58.7m, draining operating cash to NZ$1.9m

Revenue fell 23.3% on post-COVID normalisation, but a NZ$58.7m working-capital build left the lifted dividend uncovered by free cash flow.

Published 22 April 2026

Read briefing→

Get reporting-season briefings

Get full NZX result briefings by email as new coverage is published.